Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations.
about
Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improvement in Gemcitabine-Ind ...... r: Mechanistic Considerations.
@ast
Improvement in Gemcitabine-Ind ...... r: Mechanistic Considerations.
@en
type
label
Improvement in Gemcitabine-Ind ...... r: Mechanistic Considerations.
@ast
Improvement in Gemcitabine-Ind ...... r: Mechanistic Considerations.
@en
prefLabel
Improvement in Gemcitabine-Ind ...... r: Mechanistic Considerations.
@ast
Improvement in Gemcitabine-Ind ...... r: Mechanistic Considerations.
@en
P2093
P2860
P356
P1476
Improvement in Gemcitabine-Ind ...... r: Mechanistic Considerations.
@en
P2093
Abdulla K Salahudeen
Babitha Bijin
Bijin Thajudeen
Biju G Pillai
Iyad Mansour
Sangeetha Murugapandian
Sepehr Daheshpour
P2860
P304
P356
10.1159/000435807
P577
2015-05-01T00:00:00Z